Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Dr Neal Shore joins Clarity's Clinical Advisory Board 2022-05-26 21:08
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer 2022-05-26 20:27
111 to Announce First Quarter 2022 Unaudited Financial Results on June 16, 2022 - Conference Call to Follow 2022-05-26 16:59
Full-Life Technologies Completes $37 Million (USD) Series A Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Radiotechnology Production Platform 2022-05-26 12:00
Servier Announces FDA Approval of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine for Patients with Newly Diagnosed IDH1-mutated Acute Myeloid Leukemia 2022-05-26 04:45
SeekIn Receives CE Mark Approval for SeekInClarity™ Cancer Treatment Response Monitoring Kit 2022-05-25 20:30
Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody 2022-05-25 17:42
CONCEPT DESIGN MILESTONE FOR DHS SELF-SCREEN CHECKPOINT STATION ACHIEVED 2022-05-24 19:00
Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative Colitis 2022-05-24 19:00
RemeGen to Present Three Studies on Disitamab Vedotin at 2022 ASCO Annual Meeting 2022-05-24 10:27
KAZIA THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES HOSTED BY HC WAINWRIGHT AND LD MICRO 2022-05-23 20:30
VISEN Pharmaceuticals Announces Top-line Results of Phase 3 Trial of Once-Weekly Lonapegsomatropin, Demonstrating Superior Efficacy, Comparable Safety and Tolerability to Daily Growth Hormone 2022-05-23 15:57
Hanmi Fine Chemical Launches 'high-tech CDMO' Business 2022-05-23 08:32
WHO Goodwill Ambassador for Leprosy Elimination Recognized with WHO Director-General's Award for Global Health at 75th World Health Assembly 2022-05-23 00:00
Meihua International Medical Technologies Co., Ltd. Receives Notification of Deficiency from Nasdaq Related to Delayed Annual Report on Form 20-F 2022-05-20 22:57
Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences 2022-05-19 22:39
I-Mab to Hold Investor Call to Report Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab 2022-05-19 20:00
Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib's Therapeutic Potential in Treating COVID-19 Published in EMBO Molecular Medicine 2022-05-18 22:06
OriCiro Genomics expand into Boston, Open new office in North America 2022-05-18 22:00
Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes 2022-05-17 22:00
1 127 128 129 130 131 432